Institutions / Paradigm BioCapital Advisors LP
Paradigm BioCapital Advisors LP
CIK 1855655 · Institution · as of Dec 31, 2025
Portfolio value
$3.20B
Positions
28
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 28 →
| Company | Value | % of portfolio |
|---|---|---|
| Revolution Medicines, Inc. | $529.23M | 16.5% |
| Arcellx, Inc. | $373.21M | 11.6% |
| Genmab A/S | $216.83M | 6.8% |
| Tarsus Pharmaceuticals, Inc. | $209.79M | 6.5% |
| Abivax SA | $191.15M | 6.0% |
| Olema Pharmaceuticals, Inc. | $188.60M | 5.9% |
| Vaxcyte, Inc. | $187.70M | 5.9% |
| Cidara Therapeutics Inc | $167.78M | 5.2% |
| Edgewise Therapeutics, Inc. | $162.32M | 5.1% |
| Scholar Rock Holding Corp | $134.89M | 4.2% |
| Urogen Pharma Ltd | $104.77M | 3.3% |
| Crinetics Pharmaceuticals, Inc. | $102.91M | 3.2% |
| Apogee Therapeutics, Inc. | $84.78M | 2.6% |
| EyePoint, Inc. | $67.44M | 2.1% |
| Erasca, Inc.ERAS | $52.67M | 1.6% |
| BridgeBio Pharma, Inc. | $52.34M | 1.6% |
| Oruka Therapeutics, Inc. | $51.84M | 1.6% |
| Spyre Therapeutics, Inc. | $48.07M | 1.5% |
| Lexeo Therapeutics, Inc. | $47.30M | 1.5% |
| Viridian Therapeutics, Inc. | $44.91M | 1.4% |
| Ocular Therapeutix, Inc | $35.63M | 1.1% |
| Terns Pharmaceuticals, Inc. | $32.74M | 1.0% |
| BridgeBio Oncology Therapeutics, Inc.BBOT | $28.32M | 0.9% |
| Vor Biopharma Inc. | $22.89M | 0.7% |
| Assembly Biosciences, Inc.ASMB | $22.63M | 0.7% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.